Predictors of maximum efficacy of lenvatinib for real-world patients with differentiated thyroid carcinoma

Masaki, C; Sugino, K; Saito, N; Akaishi, J; Hames, KY; Tomoda, C; Suzuki, A; Matsuzu, K; Ohkuwa, K; Kitagawa, W; Nagahama, M; Ito, K

Masaki, C (通讯作者)，Ito Hosp, Dept Surg, Shibuya Ku, 4-3-6 Jingumae, Tokyo 1508308, Japan.

SURGERY TODAY, 2022; 52 (11): 1660

Abstract

Background and objectives Tyrosine kinase inhibitors (TKIs) have provided excellent clinical benefits to patients with advanced differentiated thyroid......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索